Epilepsy Monitoring Devices Market is anticipated to grow up to USD 782 million, at a CAGR of 4.6% during the forecast period 2021-2031

The epilepsy monitoring devices market was valued at USD 499 million in 2021 and it is anticipated to grow up to USD 782 million by 2031, at a CAGR of 4.6% during the forecast period.

An abrupt and uncontrollable electrical disruption of the brain is known as epilepsy. It results in modifications to the degree of consciousness, movement, and behavior. Based on different severity levels, there are numerous forms of epilepsy that are common worldwide. Depending on where and how they start in the brain, many types of epilepsy exist. Most epileptic episodes last between 30 seconds and 2 minutes. However, if epilepsy persists for more than five minutes, medical assistance must be summoned. Epilepsy can develop after conditions like meningitis, a stroke, or a closed head injury. Epilepsy's primary etiology is unknown. Computed tomography, implanted advisory systems, electromyography, magnetic resonance imaging (MRI), and EEG machines are some of the most popular epilepsy diagnostic tools. Untreated epilepsy frequently results in loss of coordination, nausea, and vomiting.

Read more about Epilepsy Monitoring Devices Market here: https://www.globalinsightservices.com/reports/epilepsy-monitoring-devices-market/

Market Trends and Drivers:

The increasing incidence and prevalence of epilepsy is boosting the growth of the market during the forecast period. The WHO estimates that five million people are given epilepsy diagnoses each year in the world. According to estimates, epilepsy affects 49 out of every 100,000 people in high-income nations. This number can reach 139 per 100,000 in low- and middle-income nations. This is probably because endemic diseases like malaria and neurocysticercosis are more common, birth traumas and injuries from auto accidents occur more frequently, the medical infrastructure varies, and there are preventive health programs and accessible care options available (in high-income countries).

Market Restraints and Challenges;

Factor such as the high cost of complex epilepsy monitoring procedures and devices is hindering the growth of the market. One of the main factors restricting the global market for epilepsy monitoring devices is the high cost of epilepsy monitoring operations and devices, particularly in developing nations with lax reimbursement systems. Devices for monitoring the brain are quite complicated, and the procedures required to use them are typically pricy.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS10282/

COVID-19 Impact:

The COVID-19 outbreak has put medical practises of all sizes under a great deal of stress, and healthcare facilities all across the world are being overrun by the massive number of patients who are coming to see them every day. Other items and services that were not essential to the COVID-19 response operations also showed signs of declining demand and procurement delays. To lower the danger of exposure to doctors, employees, and patients, as well as to conserve resources in order to handle an increase in COVID-19 patients, the majority of hospitals temporarily cancelled elective neurology treatments. Additionally, COVID-19 is increasing supply chain and logistics costs while also fueling uncertainty in important international markets. It's anticipated that this variation in market growth will continue over the upcoming quarters.

Major Players in the Global Epilepsy Monitoring Devices Market:

The key players in the global epilepsy monitoring devices market are Natus Medical, Inc. (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US), Mitsar Co., Ltd. (Russia), Rimed (US), Emotiv (US), CGX (A Cognionics Company) (US), Mindray Medical International Ltd. (China), Cadwell Industries, Inc. (US), NeuroWave Systems, Inc. (US), and MC10, Inc. (US).

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS10282/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.